Search Results 131-140 of 27403 for colitis

  1. A Study to Evaluate the Long-Term Safety and Effectiveness of Upadacitinib (ABT-494) in Subjects with Ulcerative Colitis (UC) - Mayo Clinic

    This study is designed to evaluate the long-term safety and efficacy of ABT-494 in participants with ulcerative colitis (UC) who have not responded at the end ...

  2. Cholecystitis - Symptoms and causes - Mayo Clinic

    The gallbladder is a small, pear-shaped organ on the right side of the belly (abdomen), beneath the liver. The gallbladder holds a digestive fluid (bile) that's ...

  3. Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

    Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD). Print details. Share ...

  4. An Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis - Mayo Clinic

    The purpose of the trial is to determine the safety and efficacy of RPC1063 in patients diagnosed with moderate to severe ulcerative colitis. Participation ...

  5. Inflammatory bowel disease (IBD) - Care at Mayo Clinic

    ... inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Mayo Clinic specializes in helping people with severe symptoms that haven't ...

  6. A Study to Evaluate the Safety, Effectiveness and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment - Mayo Clinic

    To evaluate a new oral treatment, ABI-M201 (or placebo) in individuals with mild to moderate Ulcerative Colitis who have sustained an inadequate response to ...

  7. Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD

    ... for treating ulcerative colitis, anti-tumor necrosis factor (TNF) agents have provided a potent tool for managing inflammatory bowel disease (IBD) symptoms.

  8. Gastroenteritis: First aid - Mayo Clinic

    Nausea and vomiting. Diarrhea. Abdominal cramps. Low-grade fever (sometimes). Depending on the cause of the inflammation, symptoms may last from ...

  9. A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) - Mayo Clinic

    A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) ... Ulcerative Colitis (UC) or Crohn's disease ...

  10. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview ... ulcerative colitis (UC). Participation eligibility. Participant eligibility ...